No black box warning on record for Lovastatin

As of the latest FDA labeling reviewed, Lovastatin (LOVASTATIN) does not carry a black box warning. Standard warnings and precautions still apply — see the full Lovastatin medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS Myopathy/Rhabdomyolysis Lovastatin, like other inhibitors of HMG-CoA reductase, occasionally causes myopathy manifested as muscle pain, tenderness or weakness with creatine kinase (CK) above ten times the upper limit of normal (ULN). Myopathy sometimes takes the form of rhabdomyolysis with or without acute renal failure secondary to myoglobinuria, and rare fatalities have occurred. The ri

No black box warning on record for Lovastatin

Other warnings & precautions

WARNINGS Myopathy/Rhabdomyolysis Lovastatin, like other inhibitors of HMG-CoA reductase, occasionally causes myopathy manifested as muscle pain, tenderness or weakness with creatine kinase (CK) above ten times the upper limit of normal (ULN). Myopathy sometimes takes the form of rhabdomyolysis with or without acute renal failure secondary to myoglobinuria, and rare fatalities have occurred. The ri

Lovastatin Black Box Warning

No black box warning on record for Lovastatin

Other warnings & precautions

Lovastatin Black Box Warning

No black box warning on record for Lovastatin

Other warnings & precautions